Live feed17:22:06·1086dSECFilingvia QuantisnowNavidea Biopharmaceuticals Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD DisclosureByQuantisnow·Wall Street's wire, on your screen.NAVB· Navidea Biopharmaceuticals Inc.Health CareOriginal source
